NCT00645736View on ClinicalTrials.gov

CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study

CompletedOBSERVATIONAL
Enrollment

788

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

November 30, 2008

Conditions
Chronic Hepatitis B
Interventions
OTHER

No intervention

No intervention

Trial Locations (1)

3002

Gilead Sciences Pty Ltd, East Melbourne

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY

NCT00645736 - CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study | Biotech Hunter | Biotech Hunter